International Journal of High Risk Behaviors and Addiction

Published by: Kowsar

Changing Trends in Drug Abuse Patterns and Seroprevalence of HIV, Hepatitis B Surface Antigen, and Hepatitis C in Substance Abusers Admitted to A Tertiary Hospital in Amritsar, India

Harsh Chalana 1 , * , Tanu Kundal 1 and Amandeep Singh Malhari 1
Authors Information
1 Department of Psychiatry, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, India
Article information
  • International Journal of High Risk Behaviors and Addiction: December 2017, 6 (4); e63202
  • Published Online: October 30, 2017
  • Article Type: Research Article
  • Received: September 10, 2016
  • Revised: January 7, 2017
  • Accepted: February 25, 2017
  • DOI: 10.5812/ijhrba.63202

To Cite: Chalana H, Kundal T, Singh Malhari A. Changing Trends in Drug Abuse Patterns and Seroprevalence of HIV, Hepatitis B Surface Antigen, and Hepatitis C in Substance Abusers Admitted to A Tertiary Hospital in Amritsar, India, Int J High Risk Behav Addict. 2017 ;6(4):e63202. doi: 10.5812/ijhrba.63202.

Abstract
Copyright © 2017, International Journal of High Risk Behaviors and Addiction. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Govt. of India . District epidemiological profiling: Fact sheet vol-1 Dec 2012. India: National AIDS control organization, Ministry of Health and Family Welfare; 2012.
  • 2. Chalana H, Singh H, Sachdeva JK, Sharma S. Seroprevalence of human immunodeficiency virus, hepatitis B surface antigen, and hepatitis C in substance dependents admitted in a tertiary hospital at Amritsar, India. Asian J Psychiatr. 2013;6(6):552-5. doi: 10.1016/j.ajp.2013.08.064. [PubMed: 24309871].
  • 3. Ray R. The extent, pattern and trends of drug abuse in India. India: National survey. Ministry of social justice and empowerment. Government of India & United Nations office on drugs and crime. Regional office for South Asia; 2004.
  • 4. Murthy P, Manjunatha N, Subodh BN, Chand PK, Benegal V. Substance use and addiction research in India. Indian J Psychiatry. 2010;52(Suppl 1):S189-99. doi: 10.4103/0019-5545.69232. [PubMed: 21836677].
  • 5. Puri P, Anand AC, Saraswat VA, Acharya SK, Dhiman RK, Aggarwal R, et al. Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India. J Clin Exp Hepatol. 2014;4(2):106-16. doi: 10.1016/j.jceh.2014.05.006. [PubMed: 25755548].
  • 6. Basu D, Kumar V, Sharma AK, Barnwal PK, Mattoo SK. Seroprevalence of anti-hepatitis C virus (anti-HCV) antibody and HCV-related risk in injecting drug users in northern India: comparison with non-injecting drug users. Asian J Psychiatr. 2013;6(1):52-5. doi: 10.1016/j.ajp.2012.08.008. [PubMed: 23380318].
  • 7. Chelleng PK, Borkakoty BJ, Chetia M, Das HK, Mahanta J. Risk of hepatitis C infection among injection drug users in Mizoram, India. Indian J Med Res. 2008;128(5):640-6. [PubMed: 19179686].
  • 8. Nelson PK, Mathers BM, Cowie B, Hagan H, Des Jarlais D, Horyniak D, et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011;378(9791):571-83. doi: 10.1016/S0140-6736(11)61097-0. [PubMed: 21802134].
  • 9. UNGASS Country Progress Report . National AIDS Control Organisation. India: Ministry of Health and Family Welfare Government of India; 2010.
  • 10. Jindal N, Arora U, Singh K. Prevalence of humanimmunodeficiency virus (HIV), Hepatitis B virus and Hepatitis C virus in three groups of population at high risk of HIV infection in Amritsar, Punjab, North India. Jpn J Infect Dis. 2008;61:79-81.
  • 11. Arora U. Seroprevalence of HIV Among Intravenous Drug Users in Amritsar: Risk Factors and Risk Behavior. J Lab Physicians. 2009;1(2):83. doi: 10.4103/0974-2727.59707. [PubMed: 21938258].
  • 12. Tiwari R, Aggarwal A, Devi P. Seroprevalence of hepatitis B, hepatitis C and human immunodeficiency viruses amongst drug users in Amritsar. Indian J Med Microbiol. 2006;24(2):151-2. [PubMed: 16687877].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments